Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

HEROINE

Financiado

Hormone-microbiome interactions as a key-player in female health

Incidence rates of inflammatory and autoimmune diseases are increasing dramatically and a clear sex bias exists in disease presentation and progression. While the underlying reasons are largely unknown, hormones are hypothesized t... ver más

31/05/2027

TUM

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

TECHNISCHE UNIVERSITAET MUENCHEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-02-01

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2021-STG: ERC STARTING GRANTS

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

TUM

1.50M€ | Lider

Proyectos interesantes

CNS2023-145286 Fisiopatología de órganos y sistemas 200K€ Cerrado

PID2021-127280OB-I00 ATLAS MICROBIANO E INTERACCIONES HUESPED-HOSPEDADOR EN LA PA... 157K€ Cerrado

FJCI-2016-28173 Microbiota y enfermedades metabólicas y autoinmunes 50K€ Cerrado

SEMICYCLE Deciphering female’s SEx hormones - MIcrobiota interactions... 1M€ Cerrado

RYC-2010-07051 Role of the intestinal microbiota in inflammatory bowel dise... Cerrado

MICROECO Microbial ecosystems biology in the human gut 1M€ Cerrado

Últimas noticias

02-12-2024: AGENCIA-VALENCIANA-D... En las últimas 48 horas el Organismo AGENCIA VALENCIANA D... ha otorgado 1 concesiones

02-12-2024: CDTI En las últimas 48 horas el Organismo CDTI ha otorgado 4 concesiones

01-12-2024: REDES En las últimas 48 horas el Organismo REDES ha otorgado 1337 concesiones

Duración del proyecto: 63 meses Fecha Inicio: 2022-02-01
Fecha Fin: 2027-05-31

Líder del proyecto

TECHNISCHE UNIVERSITAET MUENCHEN

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto Incidence rates of inflammatory and autoimmune diseases are increasing dramatically and a clear sex bias exists in disease presentation and progression. While the underlying reasons are largely unknown, hormones are hypothesized to play a central role in these discrepancies and the microbiome is linked to disease pathology. However, a key understudied player is the interplay between hormones and the microbiome in human health. Crucially, hormone-microbiome interactions in the human body are poorly understood. Microbes produce hormone-like signals and play a role in hormone metabolism and regulation, while hormones influence bacterial growth. It is currently unknown how the menstrual cycle impacts the microbiome and how disruptions of this natural cycle impact female health. I have identified unique fluctuations in microbial diversity in healthy women that are absent in men and altered in women on hormonal contraceptives. There is a lack of medical research focusing on female physiology, particularly investigating endocrinological changes and disruptions. Understanding the consequences of endocrine-related disruptions and how hormone-microbiome interactions contribute to them is a fundamental step towards precision medicine that will benefit both women and men. Therefore, I will systematically investigate hormone-microbiome interactions in (1) healthy women on and off hormonal contraceptives, (2) women at menopause and (3) infertile women receiving fertility treatment. I will integrate clinical data with state-of-the-art multi-omics profiles using computational approaches and I will combine these with mechanistic validation using bacterial strains isolated from the female subjects. At the end of my project, we will know how exogenous and endogenous hormones interact with the microbiome and how they impact female health. Further, we will identify biomarkers for optimal treatment of infertility and propose new microbiome-based therapeutic strategies for this disorder.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores